Fully Human Antibody Discovery Using Nanovials and Plasma Cells From ATX-GK™ Mice

Access the webinar recording

Thanks for your interest in our recent Fully Human Antibody Discovery Using Nanovials and Plasma Cells From ATX-GK™ Mice webinar. Please fill out your contact information, and we will email you shortly with a link and passcode to access the recording.

Our approach

Plasma cells are an important source of antibodies and are important to harvest during an antibody discovery campaign. However, because they display no to low levels of antibodies on their surface, detecting and isolating antigen-specific clones is challenging. In this webinar, scientists from Alloy Therapeutics and Partillion Biosciences talk about the opportunity and success behind integrating Partillion Biosciences Nanovial Technology into Alloy’s best-in-class Discovery to Functional Leads workflow and capture antigen-specific plasma cells to augment an antibody discovery campaign.

Learn how:

  • ATX-Gx™ industry-leading humanized mouse models can be harnessed as in vivo human antibody discovery platform for generating a robust and diverse immune response.
  • Nanovial technology can screen hundreds of thousands of fragile antibody-secreting plasma without the need for expensive instrumentation or lengthy workflows.
  • Plasma cells are a rich source of high affinity antibodies that have therapeutic potential.

Schedule a consultation

Webinar speakers

Name
By clicking submit you consent to receive email communications about Alloy Therapeutics products and services and agree to our Terms. Your data will be processed in accordance with our Privacy Policy. You may opt out at any time.